REPLIGEN CORP (RGEN) Total liabilities 2016–2025
REPLIGEN CORP (RGEN) total liabilities at each fiscal year-end, per SEC filings.
$843.6MFY2025 · since FY2016: $120.1M → $843.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $843.6M | -1.6% |
| FY2024 | $856.9M | -1.1% |
| FY2023 | $866.3M | +39.5% |
| FY2022 | $620.9M | +2.1% |
| FY2021 | $608.3M | +62.8% |
| FY2020 | $373.7M | +9.8% |
| FY2019 | $340.3M | +114.0% |
| FY2018 | $159.1M | +4.7% |
| FY2017 | $152.0M | +26.5% |
| FY2016 | $120.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice